Molecular targets for flavivirus drug discovery

Area of Science:

• * Virology
• * Infectious Diseases
• * Drug Discovery

Background:

• * Flaviviruses, including Dengue, West Nile, Yellow Fever, Japanese Encephalitis, and Tick-borne Encephalitis viruses, cause significant global human infectious diseases.
• * Current treatments for flavivirus infections are limited, with no broadly effective antiviral therapies available, leading to substantial morbidity and mortality.
• * Existing vaccines do not cover all flavivirus diseases, necessitating the development of novel therapeutic strategies.

Purpose of the Study:

• * To introduce a collection of papers focused on identifying molecular targets for antiviral drug design against flaviviruses.
• * To encourage and guide drug development efforts by reviewing the flavivirus replication cycle and potential therapeutic targets.
• * To highlight the current status of flavivirus drug discovery and suggest future research directions.

Main Methods:

• * Review of the flavivirus replication cycle.
• * Identification and discussion of key viral proteins as potential drug targets: envelope glycoprotein, NS3 protease, NS3 helicase, NS5 methyltransferase, and NS5 RNA-dependent RNA polymerase.
• * Consideration of murine models of Dengue virus disease for preclinical research.

Main Results:

• * Detailed review of the flavivirus replication cycle provides context for drug target identification.
• * Specific viral proteins, including the NS3 protease and NS5 RNA-dependent RNA polymerase, are highlighted as promising targets for antiviral drug design.
• * Emphasis is placed on the viral protease as a particularly important target for therapeutic intervention.

Conclusions:

• * The development of effective antiviral therapies is urgently needed to combat flavivirus infections.
• * Targeting specific viral proteins offers a viable strategy for designing novel antiviral drugs.
• * Continued research into flavivirus molecular targets and preclinical models is essential for advancing drug discovery efforts.